QCIG
TAK icon

Quad-Cities Investment Group’s Takeda Pharmaceutical TAK Stock Holding History

Quad-Cities Investment Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-378
Closed -$6K – 647
2019
Q3 		$6K Buy
378
+2
+0.5% +$35 0.01% 673
2019
Q2 		$8K Hold
376
– – 0.01% 652
2019
Q1 		$8K Buy
+376
New +$7.57K 0.01% 633

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Quad-Cities Investment Group's TAK Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Takeda Pharmaceutical (TAK) in Q4 2019, closing a stake of 378 shares — an estimated $6K sold.

Quad-Cities Investment Group first reported a position in TAK in Q1 2019 and held it in 3 quarters. The position peaked at $8K in Q2 2019. 339 funds tracked by Wall St. Rank hold TAK as of Q4 2019.

  • Quad-Cities Investment Group reported no remaining Takeda Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 378 Takeda Pharmaceutical shares in Q4 2019, an estimated $6K.
  • Quad-Cities Investment Group first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 3 quarters.
  • Quad-Cities Investment Group's Takeda Pharmaceutical position peaked at $8K in Q2 2019.
  • 339 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.